FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Maraviroc (Selzentry) Tablets
Status: Discontinuation
»Therapeutic Categories: Antiviral

Expand all

GlaxoSmithKline (ViiV Healthcare) (New 01/03/2023)

Company Contact Information:
888-825-5249

Presentation	Posting Date	Related Information
25 mg tablet 120 count (NDC 49702-233-08)	01/03/2023	The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024. Selzentry 150mg (49702-223-18), Selzentry 300 mg (49702-224-18) and Selzentry Oral Solution (49702-260-55) will still be available.
75 mg tablet 120 count (NDC 49702-235-08)	01/03/2023	The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024. Selzentry 150mg (49702-223-18), Selzentry 300 mg (49702-224-18) and Selzentry Oral Solution (49702-260-55) will still be available.